Spirulina and Osteoblast/Osteoclast Balance: RANKL/OPG, Wnt/LRP5, and Bone Remodelling

Osteoblast Differentiation: RUNX2 and Wnt/beta-catenin

Osteoblasts differentiate from mesenchymal stem cells (MSCs) driven by the master transcription factor RUNX2 (cbfa1), inducing osteocalcin (OCN/BGLAP), osteopontin (OPN/SPP1), bone sialoprotein (BSP), and collagen I. Wnt ligands (Wnt3a/Wnt10b) binding Frizzled-LRP5/6 co-receptor complexes activate the beta-catenin pathway: LRP5/6 Thr1479 phosphorylation recruits Axin/APC/GSK-3beta/CK1alpha destruction complex to the membrane, releasing beta-catenin from degradation (normally GSK-3beta Ser33/37/Thr41 phosphorylation → beta-TrCP ubiquitination → proteasome). Nuclear beta-catenin displaces TCF/LEF corepressors (Groucho/TLE) for RUNX2/TCF-driven osteoblast gene transcription.

RANKL-OPG Axis: Osteoclast Regulation

Receptor activator of NF-kB ligand (RANKL/TNFSF11) is expressed by osteoblasts, osteocytes, and Th17 cells; it binds RANK on osteoclast precursors, activating TRAF6 → NF-kB → NFATc1 (master osteoclast transcription factor) and c-Fos/AP-1. NFATc1 drives osteoclast differentiation genes: TRAP (tartrate-resistant acid phosphatase), cathepsin K (CtsK, major collagenase), ATP6V0D2 (proton pump for acid secretion), and OSCAR. Osteoprotegerin (OPG/TNFRSF11B), a decoy receptor for RANKL secreted by osteoblasts, blocks RANK binding, restraining osteoclastogenesis. The RANKL/OPG ratio determines bone remodelling balance. Inflammatory cytokines (TNF-alpha, IL-1beta, IL-6, IL-17) upregulate RANKL, tilting toward bone resorption.

NF-kB and Inflammatory Bone Loss

NF-kB is activated in osteoclast precursors by RANKL-RANK-TRAF6 and by TNF-alpha (TNF-R1/TRADD), driving NFATc1 (NF-kB transactivates NFATc1 promoter) and M-CSF receptor (CSF1R) expression. Simultaneously, NF-kB in osteoblasts suppresses RUNX2 transcription (p65-RUNX2 direct interaction) and upregulates RANKL expression, creating a feed-forward bone loss loop in inflammatory conditions. Spirulina's PCB-driven NF-kB suppression thus: (1) reduces RANKL expression in osteoblasts; (2) attenuates NFATc1 induction in osteoclast precursors; (3) preserves RUNX2 activity in MSC/osteoblast differentiation, shifting the RANKL/OPG ratio toward bone preservation.

Nrf2 and Osteoblast Oxidative Protection

Osteoblast differentiation is inhibited by oxidative stress: ROS activate FoxO1/3/4 which compete with beta-catenin for the co-activator CBP/p300, diverting beta-catenin from Wnt/TCF-RUNX2 osteoblast genes. Nrf2 activation reduces the ROS that drives FoxO-beta-catenin competition, preserving beta-catenin/TCF-RUNX2 activity. Additionally, Nrf2 directly upregulates NQO1, which reduces vitamin K2 (menaquinone) metabolites that support carboxylation of osteocalcin (gamma-carboxylation requires GGCX enzyme). Spirulina's Nrf2 activation thus protects osteoblast function through multiple redox and vitamin K-linked mechanisms.

Vitamin D and Parathyroid Hormone Integration

Calcitriol (1,25(OH)2D3) via VDR on osteoblasts: (1) induces RANKL expression (driving bone remodelling, which releases matrix-bound growth factors TGF-beta, IGF-1); (2) induces osteocalcin and alkaline phosphatase (ALPL); (3) through receptor activator synergy with PTH. PTH (PTHR1/cAMP/PKA) also upregulates RANKL in osteoblasts (net catabolic at continuous exposure, anabolic when pulsatile). Spirulina's NF-kB suppression of VDR signalling attenuation (RANKL arm) and preservation of VDR-Nrf2 cooperativity creates a net bone-protective context.

Manganese and Bone Matrix Synthesis

Manganese (Mn) is required for the glycosyltransferases synthesising proteoglycan chains (chondroitin sulfate, heparan sulfate) in cartilage and bone matrix, and for Mn-SOD2 activity in osteoblast mitochondria. Spirulina contains approximately 0.5-2 mg Mn/100 g DW, contributing to the trace element requirements for matrix synthesis. SOD2 (MnSOD) induction via Nrf2-SIRT3 protects osteoblast mitochondria from ROS-driven apoptosis during the high-energy demands of bone matrix synthesis.